Elevate Credit Releases Potential Pricing for IPO
Elevate Credit has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
All Work
Chris Lange
Acorn Proves Investors Still Willing to Buy Into Chinese Growth Story
Acorn International led the bulls in Monday’s session following the announcement of a newly authorized share repurchase plan.
Clearside Files for IPO
Clearside Biomedical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Apollo Education Rises Despite Missed Earnings
Apollo Education Group reported disappointing fiscal first-quarter financial results before the markets opened on Monday.
Is Thermo Fisher Overpaying for Affymetrix?
Affymetrix was absolutely soaring early on Monday on word that it will be acquired. Thermo Fisher Scientific is the buyer.
5 Top Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Alcoa and some of the major companies reporting their quarterly results this week.
5 Stocks That Destroyed Shareholders This Past Week
24/7 Wall St. has tracked five companies in which shareholders were hurt by bad news in the first week of trading for 2016.
SEC Bars Hedge Fund Manager From Supervisory Role
The U.S. Securities and Exchange Commission (SEC) announced that hedge fund manager Steven A. Cohen will be prohibited from supervising funds that manage outside money until 2018 in order to settle charges for failing…
Athersys Soars on Japanese License Deal
Athersys has announced a partnership and license agreement that will focus on the development and commercialization of novel cell therapy treatments.
Container Store Tanks on Missed Earnings and Guidance
Container Store reported disappointing fiscal third-quarter financial results after the markets closed on Thursday.
Ardelyx Gears Up for Secondary Offering
Ardelyx recently filed with the U.S. Securities and Exchange Commission (SEC) regarding a secondary offering.
Collegium Pharmaceutical Prices Secondary Offering
Collegium Pharmaceutical has filed with the U.S. Securities and Exchange Commission (SEC) regarding its secondary offering.
Jaguar Animal Health Gears Up for Secondary Offering
Jaguar Animal Health has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) for a secondary offering.
The 2016 Bullish and Bearish Case for Caterpillar and DuPont
For the most part the outlook is not exactly clear for Caterpillar or DuPont going into 2016. Both Dow stocks came out on the negative side in 2015.
The 2016 Bullish and Bearish Case for Disney
Walt Disney has been a top-performing Dow stock for years, and it seems like this company can do no wrong, the way that it left 2015.
The 2016 Bullish and Bearish Case for Home Depot
Strong fundamentals, earnings and a solid balance sheet made Home Depot a top performer in 2015. But will this performance carry over to 2016?
Bed Bath & Beyond Earnings Meet Estimates
Bed Bath & Beyond reported its fiscal third-quarter financial results and offered guidance after the markets closed on Thursday.
Dynavax Soars on Positive Late Stage Results
Dynavax Technologies led the bulls on Thursday with positive results from a late stage clinical trial, on another consecutive down day for the broad markets.
The 2016 Bullish and Bearish Case for Nike
Nike was the top-performing Dow component in 2015. The question is whether this company can have a repeat performance in 2016.
The 2016 Bullish and Bearish Case for McDonald’s
McDonald's stock has been on fire over the past six months, and it remains a solid pick for investors seeking dividends and a degree of safety. But how will this fast-food giant perform in…